CompletedPhase 2NCT06352372
Safety and Efficacy of tPBM for Epileptiform Activity in Autism
Studying Cerebral malformation with epilepsy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Richard Frye
- Principal Investigator
- Richard E Frye, M.D., Ph.DRossignol Medical Center, Phoenix AZ
- Intervention
- noninvasively delivered near infra-red (NIR) light - transcranial Photobiomodulation (tPBM)(device)
- Enrollment
- 6 enrolled
- Eligibility
- 4-12 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- Rossignol Medical Center, Phoenix, Arizona, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06352372 on ClinicalTrials.govOther trials for Cerebral malformation with epilepsy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05527093Cartography of Social Cognition Network and Their Alterations in Patients With EpilepsyAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGNCT04917939Gene Expression Changes of Brain Tissue in Human Temporal Lobe Epilepsy With Hippocampal SclerosisSecond Affiliated Hospital, School of Medicine, Zhejiang University